Altamira Therapeutics Ltd. Other Shortterm Employee Benefits
Altamira Therapeutics Ltd. (CYTOF) reported Other Shortterm Employee Benefits of $304.71 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:OtherShorttermEmployeeBenefits · last filed 2025-04-30
CHF
| Period end | Other Shortterm Employee Benefits 12 month |
|---|---|
| 2023-12-31 | 293.75K CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | 294.02K CHF 20-F/A · filed 2024-04-22 |
| 2021-12-31 | 275.26K CHF 20-F/A · filed 2024-04-22 |
| 2020-12-31 | 116.29K CHF 20-F · filed 2023-05-16 |
| 2019-12-31 | 217.45K CHF 20-F · filed 2022-04-12 |
| 2018-12-31 | 188.14K CHF 20-F · filed 2021-03-31 |
| 2017-12-31 | 277.47K CHF 20-F · filed 2020-04-16 |
| 2016-12-31 | 301.54K CHF 20-F · filed 2019-03-14 |
| 2015-12-31 | 191.08K CHF 20-F · filed 2018-03-22 |
USD
| Period end | Other Shortterm Employee Benefits 12 month |
|---|---|
| 2024-12-31 | $304.71K 20-F · filed 2025-04-30 |
| 2023-12-31 | $326.94K 20-F · filed 2025-04-30 |
| 2022-12-31 | $307.87K 20-F · filed 2025-04-30 |